These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6015490)

  • 1. [Some knowledges on the potency of heparin fractions obtained by gel filtration].
    Nagasawa K; Kimura T
    Eisei Shikenjo Hokoku; 1970; 88():4-7. PubMed ID: 6015490
    [No Abstract]   [Full Text] [Related]  

  • 2. The potency of heparin fractions obtained by gel filtration.
    Hall M; Ricketts CR; Michael SE
    J Pharm Pharmacol; 1969 Sep; 21(9):626-8. PubMed ID: 4390347
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 4. The heterogeneity of heparins.
    Lasker SE
    Fed Proc; 1977 Jan; 36(1):92-7. PubMed ID: 556607
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant and antilipemic activities of a heparin proteoglycan from bovine intestinal mucosa.
    Seethanathan P; Ehrlich K
    Thromb Res; 1980 Jul 1-15; 19(1-2):95-102. PubMed ID: 7444861
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of endothelin-1 production in cultured human umbilical vein endothelial cells by heparin fractions separated by strong anion exchange chromatography.
    Reantragoon S; Arrigo LM; Dweck HS; Rosenfeld L
    Arch Biochem Biophys; 1996 Mar; 327(2):234-8. PubMed ID: 8619608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-inhibitable lectins: marked similarities in chicken and rat.
    Roberson MM; Ceri H; Shadle PJ; Barondes SH
    J Supramol Struct Cell Biochem; 1981; 15(4):395-402. PubMed ID: 7299837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for separation of heparin species from biological samples by ethanol precipitation of compounds solubilized in guanidine hydrochloride.
    Ruggiero M; Caldini R; Chevanne M; Melli M; Pacini S; Gulisano M; Vannucchi S
    Ital J Anat Embryol; 2001; 106(1):35-46. PubMed ID: 11410997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantitation of heparins by microelectrophoresis on agarose gel.
    Jaques LB; Wollin A
    Anal Biochem; 1973 Mar; 52(1):219-33. PubMed ID: 4735267
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation of beef and pig mucosal heparins by NMR spectroscopy.
    Casu B; Guerrini M; Naggi A; Torri G; De-Ambrosi L; Boveri G; Gonella S; Ronzoni G
    Thromb Haemost; 1995 Oct; 74(4):1205. PubMed ID: 8560442
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue distribution and antithrombotic activity of unlabeled or 14C-labeled porcine intestinal mucosal heparin following administration to rats by the oral route.
    Hiebert LM; Wice SM; Ping T; Hileman RE; Capila I; Linhardt RJ
    Can J Physiol Pharmacol; 2000 Apr; 78(4):307-20. PubMed ID: 10772058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular weight dependence of heparin anti-factor Xa activity: influence of method.
    Anderson W; Harthill JE
    Thromb Res; 1981 Mar; 21(6):557-64. PubMed ID: 7271944
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies in man and experimental animals of a low molecular weight heparin fraction.
    Thomas DP; Merton RE; Lewis WE; Barrowcliffe TW
    Thromb Haemost; 1981 Jun; 45(3):214-8. PubMed ID: 7281101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells.
    Reantragoon S; Arrigo LM; Seoud MM; Dweck HS; Rosenfeld L
    Arch Biochem Biophys; 1994 Nov; 314(2):315-22. PubMed ID: 7979371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.